Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2025 Earnings Call Transcript February 12, 2025
Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.28.
Operator: Good day, everyone, and welcome to the Aytu BioPharma Fiscal 2025 Q2 Earnings Call. At this time, all participants have been placed on a listen-only. [Operator Instructions] It is now my pleasure to turn the floor over to your host, Robert Blum. Sir, the floor yours.
Robert Blum: All right. Thank...
